Nephrocare Health Services Peer Comparison

NSE: NEPHROPLUS | BSE: 544647

₹697.05

₹-9.70 (-1.37%)

As on 04-Sep-2026 15:53IST

Market cap

₹7,012 Cr

Revenue (TTM)

₹999 Cr

P/E Ratio

91.3

P/B Ratio

6.2

Div. Yield

0 %

Edit

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Market cap (₹ Cr)	7,012	39,493	32,095	31,470	15,412
Revenue (₹ Cr)	999	4,683	4,213	2,891	857
Net Profit (₹ Cr)	76.84	552.34	190.80	546.30	187.49
Net Margin (%)	7.51	11.55	4.49	18.23	21.32
RoE (%)	9.22	14.93	9.45	23.03	20.58
Price to Earnings	91.26	71.01	157.10	58.07	82.20
Price-To-Book	6.18	9.61	8.48	12.04	15.30

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Operating Revenue	998.85	4,410.27	3,904.60	2,762.91	814.20
Total Income	1,023.36	4,514.67	3,930.80	2,864.18	835.00
Total Expenditure	771.88	3,486.05	3,090.00	1,980.40	477.27
EBITDA	226.96	924.22	814.60	782.52	336.94
Depreciation	90.67	222.54	283.20	161.80	91.82
EBIT	136.30	701.68	531.40	620.71	245.11
Interest	60.24	90.05	215.10	22.80	33.23
Other Income	24.51	104.41	26.20	101.27	20.80
Exceptional Items	--	-1.02	-11.20	-30.09	--
Profit before Tax	97.47	715.02	333.90	669.09	232.68
Provision for Tax	20.63	160.95	91.90	159.33	59.70
Profit after Tax	76.84	554.07	242.00	509.75	172.98

Liabilities (₹ Cr)

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Shareholder's Funds	1,116.49	3,961.57	2,247.40	2,508.14	957.15
Minority Interest	--	22.71	311.10	33.14	--
Non-Current Liabilities	21.00	1,277.95	3,833.90	66.56	426.03
Current Liabilities	299.41	627.13	1,238.90	450.62	123.86
Total Liabilities	1,467.32	5,905.00	7,690.70	3,139.97	1,507.05

Assets (₹ Cr)

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Non-Current Assets	597.74	4,214.44	6,693.90	1,491.97	1,185.15
Current Assets	839.17	1,674.92	937.40	1,566.49	321.90
Total Assets	1,467.32	5,905.00	7,690.70	3,139.97	1,507.05
Total Debt*	23.02	631.08	3,244.00	0.00	0.00
Net Current Assets	539.76	1,047.79	-301.50	1,115.88	198.04
Contingent Liabilities	--	100.01	81.10	16.76	0.13

Cashflow (₹ Cr)

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Cash From Operating Activities	232.58	714.39	510.80	635.61	270.59
Cash Flow from Investing Activities	-410.44	-1,089.11	-1,451.70	-421.86	-174.22
Cash from Financing Activities	157.11	271.85	940.30	-263.57	-69.49
Net Cash Inflow / Outflow	-20.75	-102.87	-0.60	-49.83	26.88

Ratios

Profitability Ratios

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
ROCE (%)	16.18	19.38	11.51	29.56	30.28
ROE (%)	9.22	15.12	11.04	22.37	19.91
ROA (%)	6.37	10.43	3.64	17.92	12.44
EBIT Margin (%)	25.18	23.32	21.53	31.99	43.94
Net Margin (%)	7.51	12.27	6.16	17.80	20.72
Cash Profit Margin (%)	16.77	17.61	13.45	24.31	32.52

Growth Ratios

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Revenue Growth (%)	32.16	19.44	28.65	12.25	19.49
EBIT Growth (%)	39.14	6.57	1.93	12.01	22.71
Net Profit Growth (%)	14.52	15.11	-41.66	3.56	20.30
EPS Growth (%)	-89.93	15.54	-37.22	3.39	19.99
Book Value Growth (%)	93.44	16.51	5.13	15.41	21.86

Valuation Ratios

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Price / Earnings	66.02	46.44	103.16	43.61	51.24
Price / Book Value	4.62	6.55	11.08	9.01	9.29
Dividend Yield (%)	0.00	0.05	0.00	1.56	0.23
EV/EBITDA	19.25	24.64	33.39	23.88	24.63
Market Cap (₹ Cr)	5,072.73	25,841.07	24,901.98	22,015.15	8,864.05

Solvency Ratios

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debt to Equity	0.02	0.16	1.44	0.00	0.00
Short term debt to equity ratio	0.01	--	0.15	--	--
Current Ratio	2.80	2.67	0.76	3.48	2.60
Quick Ratio	2.69	2.54	0.68	3.38	2.56
Interest Coverage	2.62	8.94	2.55	30.35	8.00

Operating Efficiency Ratios

	Nephrocare Health Services	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debtors to sales (%)	31.73	9.32	14.19	4.01	2.56
Asset Turnover	0.83	0.83	0.59	0.97	0.59
Receivable days	106.58	29.09	44.38	13.13	7.98
Inventory Days	10.90	6.05	7.52	5.28	2.20
Payable days	205.92	80.04	133.54	118.67	136.27
Cash Conversion Cycle	-88.44	-44.90	-81.64	-100.26	-126.08